The Effects of the Be Mindful Intervention in Previously Depressed Individuals Experiencing Subclinical Symptoms

May 17, 2023 updated by: Meghan Bauer, State University of New York at Buffalo

The Effects of the "Be Mindful" Intervention in Previously Depressed College Students Currently Experiencing Subclinical Symptoms of Depression

This study is designed to help individuals cope with their current depressive symptoms by providing them access to a 4-week online Mindfulness-Based Cognitive Therapy: Be Mindful. Research has shown that completion of the Be Mindful intervention can reduce depressive symptoms in a community sample, and this study aims to evaluate if it can also help reduce depressive symptoms in individuals with a confirmed history of depression. Participants will either receive the intervention at the start of the study or four months after the start of the study (i.e., at 3-month follow-up), which will allow research staff to assess if reductions in depression are due to the intervention or something else. Research staff will also evaluate if the reduction in depressive symptoms lasts over the three months following intervention, and will investigate possible reasons for the change in depression (i.e., why the intervention produces change).

Study Overview

Detailed Description

Participant outcome variables will be assessed weekly for the first month after baseline. This will include the primary dependent variable (i.e., depressive symptoms), but will also include variables that will be explored as potential mechanisms of change (i.e., mindfulness, decentering, rumination, worry, self-compassion, and dysfunctional attitudes). The final weekly assessment will represent the Post-Intervention assessment.

Brief follow-up assessments of the primary dependent variable will be given 1-month and 2-months after the final weekly questionnaire. There will be a 3-month assessment that measures potential mechanisms of change in addition to the primary dependent variable.

After the 3-month follow-up, the Waitlist Control condition will be given access to the intervention. All participants (i.e., in both conditions) will be asked to complete another month of weekly questionnaires. These questionnaires will be identical to the first set of weekly questionnaires, and will allow mechanisms of change to be evaluated in the Waitlist Control condition.

Study Type

Interventional

Enrollment (Actual)

137

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Buffalo, New York, United States, 14260
        • State University of New York at Buffalo (SUNY at Buffalo)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • currently experiencing mild to moderate depressive symptoms (Patient Health Questionnaire 9 Current scores between 5 and 14)
  • meet Diagnostic and Statistical Manual of Mental Disorders (fifth edition; DSM-5) criteria for Past Major Depressive Disorder (determined by clinical interview)

Exclusion Criteria:

  • responses suggest they have never experienced a Major Depressive Episode
  • responses suggest they are not currently experiencing sub-threshold symptoms of depression
  • they state they are not open to learning mindfulness or meditation techniques
  • they indicate they are currently receiving therapeutic treatment for depression or stress management elsewhere
  • they indicate their age is not between 18 and 65
  • they state they do not currently live in New York State

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The Intervention condition will be provided with access to the 4-week online Mindfulness-Based Cognitive Therapy course "Be Mindful" immediately after randomization to group.
The online 4-week Be Mindful intervention was designed to follow the same outline as typical in-person 8-week MBCT courses. Week 1 and Week 2 introduce the topic of mindfulness and encourage its daily use, whereas Week 3 and Week 4 teach the individual to decenter from thoughts and utilize mindfulness when coping with stressors. Each week focuses on a separate mindfulness topic, which is initially presented to the individual in a short (under 5 minute) video containing didactic information and an overview of the experiential activities that will be introduced in subsequent videos. The intervention is provided entirely through audio, video, and text provided on the Be Mindful website (BeMindfulOnline.com).
Other: Waitlist Control
The Waitlist Control condition will be provided with access to the 4-week online Mindfulness-Based Cognitive Therapy course "Be Mindful" approximately 4 months after randomization to group.
The online 4-week Be Mindful intervention was designed to follow the same outline as typical in-person 8-week MBCT courses. Week 1 and Week 2 introduce the topic of mindfulness and encourage its daily use, whereas Week 3 and Week 4 teach the individual to decenter from thoughts and utilize mindfulness when coping with stressors. Each week focuses on a separate mindfulness topic, which is initially presented to the individual in a short (under 5 minute) video containing didactic information and an overview of the experiential activities that will be introduced in subsequent videos. The intervention is provided entirely through audio, video, and text provided on the Be Mindful website (BeMindfulOnline.com).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change in Depressive Symptoms from Baseline as Measured by the Patient Health Questionnaire 9 Post-Intervention
Time Frame: weekly during intervention, approximately 1-2 months
Participants are asked to rate items on a scale of 0 (Not at all) to 3 (Nearly every day).
weekly during intervention, approximately 1-2 months
Mean Change in Depressive Symptoms from Baseline as Measured by the Patient Health Questionnaire 9 at 3-Month Follow-Up
Time Frame: at regular intervals until 3-month follow-up (approximately 4-5 months after the start of the study)
Participants are asked to rate items on a scale of 0 (Not at all) to 3 (Nearly every day).
at regular intervals until 3-month follow-up (approximately 4-5 months after the start of the study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change in Mindfulness from Baseline as Measured by the Five Factor Mindfulness Questionnaire Short Form
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (never or rarely true) to 5 (very often or always true).
through study completion, which can take up to 6 months
Mean Change in Decentering from Baseline as Measured by the Toronto Mindfulness Scale
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 0 (not at all) to 4 (very much).
through study completion, which can take up to 6 months
Mean Change in Rumination from Baseline as Measured by the Ruminative Response Questionnaire
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (Almost never) to 4 (Almost always).
through study completion, which can take up to 6 months
Mean Change in Worry from Baseline as Measured by the Penn State Worry Questionnaire
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (Not at all typical of me) to 5 (Very typical of me).
through study completion, which can take up to 6 months
Mean Change in Self-Compassion from Baseline as Measured by the Self-Compassion Scale Short Form
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (Almost never) to 4 (Almost always).
through study completion, which can take up to 6 months
Mean Change in Dysfunctional Attitudes from Baseline as Measured by the Dysfunctional Attitudes Scale (Short Form 1)
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (totally agree) to 4 (totally disagree).
through study completion, which can take up to 6 months
Mean Change in Dysfunctional Attitudes from Baseline as Measured by the Rosenberg Self-Esteem Scale
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 0 (strongly disagree) to 3 (strongly agree).
through study completion, which can take up to 6 months
Mean Change in Dysfunctional Attitudes from Baseline as Measured by the Single-Item Self-Esteem Scale
Time Frame: through study completion, which can take up to 6 months
Participants are asked to rate items on a scale of 1 (Not Very True of Me) to 5 (Very True of Me).
through study completion, which can take up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meghan E Bauer, MA, State University of New York at Buffalo
  • Principal Investigator: John E Roberts, PhD, State University of New York at Buffalo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2021

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

August 1, 2022

Study Registration Dates

First Submitted

February 1, 2021

First Submitted That Met QC Criteria

February 4, 2021

First Posted (Actual)

February 5, 2021

Study Record Updates

Last Update Posted (Actual)

May 18, 2023

Last Update Submitted That Met QC Criteria

May 17, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Symptoms

Clinical Trials on Be Mindful

3
Subscribe